Aeterna Zentaris Inc. (AEZS) SEC Filing 20-F Annual report for the fiscal year ending Saturday, December 31, 2016

Aeterna Zentaris Inc.

CIK: 1113423 Ticker: AEZS

View differences made from one year to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..


Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: AEZS
CIK: 1113423
Form Type: 20-F Annual Report
Accession Number: 0001113423-17-000010
Submitted to the SEC: Wed Mar 15 2017 7:15:20 PM EST
Accepted by the SEC: Thu Mar 16 2017
Period: Saturday, December 31, 2016
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: